Reuters logo
6 months ago
BRIEF-Albany Molecular Research enters into agreement with pharmaceutical group Ferrer, Accord Healthcare
February 21, 2017 / 1:55 PM / 6 months ago

BRIEF-Albany Molecular Research enters into agreement with pharmaceutical group Ferrer, Accord Healthcare

Feb 21 (Reuters) - Albany Molecular Research Inc:

* Albany Molecular Research Inc - entered into an agreement with pharmaceutical group Ferrer and Accord Healthcare, Inc.

* Albany Molecular - agreement to develop, manufacture undisclosed complex parenteral drug product for registration, subsequent commercialization in u.s.

* Albany molecular - under terms, amri to work with ferrer to develop, initially provide cgmp manufacturing, analytical support for registration of new product

* Albany molecular research inc - accord healthcare to be responsible for advancing product candidate through regulatory submission, commercialization Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below